Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;185(2):343-352.
doi: 10.1111/bjd.19880. Epub 2021 Apr 28.

Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group

R Schneider  1   2 , D Reinau  1   2 , S Stoffel  1 , S S Jick  3   4 , C R Meier  1   2   3 , J Spoendlin  1   2
Affiliations

Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group

R Schneider et al. Br J Dermatol. 2021 Aug.

Erratum in

  • Corrigenda.
    [No authors listed] [No authors listed] Br J Dermatol. 2022 Dec;187(6):1060-1070. doi: 10.1111/bjd.21883. Br J Dermatol. 2022. PMID: 36464937 No abstract available.

Abstract

Background: Case-control studies report a dose-dependent increased risk of skin cancer in users of hydrochlorothiazide (HCTZ) vs. nonusers. The degree to which other thiazides and thiazide-like diuretics (TZs) are associated with skin cancer is less certain.

Objectives: To assess the risk of skin cancer in new users of different TZs compared with new users of calcium channel blockers (CCBs).

Methods: We conducted a cohort study using a UK primary-care database (1998-2017), including 271 154 new TZ users [87·6% bendroflumethiazide (BFT), 5·8% indapamide and 3·6% HCTZ] and 275 263 CCB users. The outcomes were basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and cutaneous malignant melanoma (CMM). We estimated incidence rates (IRs) and IR ratios (IRRs) in short-term (< 20 prescriptions) and long-term (≥ 20 prescriptions) users of TZs and CCBs using negative binomial regression, and calculated rate differences (RDs) for selected results. We used fine stratification on the propensity score (PS) to control for 23 baseline covariates.

Results: Long-term use of HCTZ increased absolute and relative risks of SCC [PS-weighted IRR 1·95; 95% confidence interval (CI) 1·87-2·02; RD per 100 000 person-years 87.4], but not of BCC or CMM. Long-term use of indapamide was associated with an increased incidence of CMM (IRR 1·43; 95% CI 1·35-1·50). BFT was not meaningfully associated with the risk of any type of skin cancer.

Conclusions: Our results corroborate the previously reported increased risk of SCC (but not of BCC or CMM) for long-term use of HCTZ. BFT may be a safer alternative for patients at increased risk of skin cancer.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Moser M, Feig PU. Fifty years of thiazide diuretic therapy for hypertension. Arch Intern Med 2009; 169:1851-6.
    1. Williams B, Mancia G, Spiering W et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press 2018; 27:314-40.
    1. Whelton PK, Carey RM. The 2017 clinical practice guideline for high blood pressure. JAMA 2017; 318:2073-4.
    1. Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf 2002; 25:345-72.
    1. Kreutz R, Algharably EAH, Douros A. Reviewing the effects of thiazide and thiazide-like diuretics as photosensitizing drugs on the risk of skin cancer. J Hypertens 2019; 37:1950-8.

MeSH terms